Anticorps Recombinant de lapin anti-CD107a / LAMP1

CD107a / LAMP1 Recombinant Antibody for FC (Intra)

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC (Intra)

Conjugaison

CoraLite® Plus 647 Fluorescent Dye

CloneNo.

H4A3

N° de cat : CL647-65549

Synonymes

CD107a, LAMP1, CD107 antigen-like family member A, CD107a/LAMP1, H4A3



Applications testées

Résultats positifs en FC (Intra)cellules Jurkat

Dilution recommandée

ApplicationDilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 µl per 10^6 cells in a 100 µl suspension or 5 µl per 100 µl of whole blood.
Sample-dependent, check data in validation data gallery

Informations sur le produit

CL647-65549 cible CD107a / LAMP1 dans les applications de FC (Intra) et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Cellules adhérentes humaines de sang périphérique
Nom complet lysosomal-associated membrane protein 1
Masse moléculaire calculée45 kDa
Numéro d’acquisition GenBankBC006345
Symbole du gène LAMP1
Identification du gène (NCBI) 3916
Conjugaison CoraLite® Plus 647 Fluorescent Dye
Excitation/Emission maxima wavelengths654 nm / 674 nm
Forme Liquide
Méthode de purification Purification par affinité
Tampon de stockage PBS with 0.09% sodium azide and 0.5% BSA
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

LAMP1 (also known as CD107a) is a 90-120 kDa heavily glycosylated membrane protein enriched in the lysosomal membrane. LAMP1 functions to provide selectins with carbohydrate ligands. This protein has also been shown to be a marker of degranulation on lymphocytes such as CD8+ and NK cells and may also play a role in tumor cell differentiation and metastasis.

Protocole

Product Specific Protocols
FC protocol for CL Plus 647 CD107a / LAMP1 antibody CL647-65549Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}